SCHEMBL3374664

SCHEMBL3374664

CCc1cnc(N2CCC(Oc3ccc(-c4ccc(-n5cncn5)nc4C)cc3)CC2)nc1

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 17/20 0.48
ACACB O00763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3376775 0.85 GPR119 (0.46) GPR119ACACB
SCHEMBL3374582 0.82 GPR119 (0.45) GPR119ACACB
SCHEMBL1937644 0.80 GPR119 (0.42) GPR119
SCHEMBL3347542 0.79 GPR119 (0.52) GPR119
SCHEMBL3374846 0.79 KCNH2 (0.44)
SCHEMBL3375030 0.78 GPR119 (0.40) GPR119
Hydrochloric Acid SCHEMBL3371740 0.78 KCNH2 (0.43)
SCHEMBL3373619 0.76 CHEK2 (0.47) GPR119
SCHEMBL15253315 0.74 GPR119 (0.58) GPR119
SCHEMBL3696482 0.72 GPR119 (0.40) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010048149-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2010-04-29 WO disclosed
WO-2010048149-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2010-04-29 WO disclosed